Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report

Implications of the USP10-HDAC6 axis in lung cancer – A path to precision medicine

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC

Incidence of Stage I NSCLC at Diagnosis Up in the U.S.

Patients with stage IV non-small cell lung cancer who are 65 years of age or older may be undertreated

Investigating balance, gait, and physical function in people who have undergone thoracic surgery for a diagnosis of lung cancer: A mixed-methods study

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1-rearranged advanced non-small cell lung cancer (NSCLC) in Canada

Construction of ceRNA network to identify the lncRNA and mRNA related to non-small cell lung cancer

Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score

NIH study illuminates origins of lung cancer in never smokers